The effect of margins on the clinical management of ductal carcinoma in situ of the breast

Journal of Surgical Oncology

Volumn 98, Issue 8, 2008, Pages 579-584

  Meijnen, Philip ^a   Gilhuijs, Kenneth G ^a   Rutgers, Emiel J Th ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

Breast cancer; Breast conserving treatment; Ductal carcinoma in situ (DCIS); Margins; Mastectomy

Indexed keywords

TAMOXIFEN;

BREAST BIOPSY; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; HUMAN; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE CARE; PRIORITY JOURNAL; RECURRENT CANCER; REVIEW; TUMOR LOCALIZATION; TUMOR VOLUME;

BIOPSY; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MASTECTOMY; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS;

EID: 58149293823     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21041     Document Type: Review

References (62)

1. Bloodgood JC: Comedo carcinoma (or comedo-adenoma) of the female breast. Am J Cancer 1935:22:842-853.
2. Sanders ME, Schuyler PA, Dupont WD, et al.: The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer 2005;103:2481-2484.
3. Carter D, Smith RR: Carcinoma in situ of the breast. Cancer I977;40:l189-1193.
4. Shah JP, Rosen PP, Robbins GF: Pitfalls of local excision in the treatment of carcinoma of the breast. Surg Gynecol Obstet 1973; 136:721-725.
5. Lagios MD, Westdahl PR, Margolin FR, et al.: Duct carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer 1982;50: 1309-1314.
6. Fisher B, Bauer M, Margolese R, et al.: Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment ofbreast cancer. N Engl J Med 1985;312:665-673.
7. Bijker N, Meijnen P, Peterse JL, et al.: Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: Ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853-A study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group, J Clin Oncol 2006;24:3381-3387.
8. Emdin SO, Granstrand B, Ringberg A, et al.: SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening. Ada Oncol 2006;45:536-543.
9. Fisher B. Land S, Mamounas E, et al.: Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the national surgical adjuvant breast and bowel project experience. Semin Oncol 2001;28:400-418.
10. Houghton J, George WD, Cuzick J, et al.: Radiotherapy and tamoxifen in women with completely excised ductal carcinoma insitu of the breast in the UK, Australia, and New Zealand: Randomised controlled trial, Lancet 2003;362:95-102. 32,
11. Faverly DR. Burgers L, Bult P, et al.: Three dimensional imaging of mammary ductal carcinoma in situ: Clinical implications. Semin Diagn Pathol 1994;11:193-198. 33.
12. Holland R, Hendriks JH, Vebeek AL, et al.: Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet 1990;335:519-522.
13. Faverly DR, Hendriks JH, Holland R: Breast carcinomas of limited extent: Frequency, radioiogic-pathologic characteristics, and surgical margin requirements. Cancer 2001;91:647-659.
14. Carlson GW, Page A, Johnson E, et al.: Local recurrence of ductal carcinoma in situ after skin-sparing mastectomy. J Am Coll Surg 2007;204:1074-1078.
15. Schouten vander Velden AP. van Vugt R, van Dijck JA, et al.: Local recurrences after different treatment strategies for ductal carcinoma in situ of the breast: A population-based study in the East Netherlands. Int J Radiat Oncol Biol Phys 2007;69:703-710.
16. Baxter NN, Virnig BA, Durham SB. et al.: Trends in the treatment, of ductal carcinoma in situ of the breast. J Natl Cancer Inst 2004;96:443-448.
17. Rakovitch E, Pignol JP, Chartier C, et al.: The management of 38, ductal carcinoma in situ of the breast: A screened population-based analysis, Breast Cancer Res Treat 2007;101:335-347.
18. Schouten vander Velden AP, van Dijck JA, Wobbes T: Variations 39, in treatment of ductal carcinoma in situ of the breast: A population-based study in the East Netherlands. Eur J Surg Oncol 20Q7;33:424-429.
19. Katz SJ, Lantz PM, Janz NK, et al.: Patterns and correlates of local therapy for women with ductal carcinorna-in-situ. J Clin Oncol 2005;23:3001-3007.
20. deRoos MA, Pijnappel RM, Groote AD, etal.: Ductal carcinoma in situ presenting as microcalcifications: The effect of stereotactic large-core needle biopsy on surgical therapy. Breast 2004; 13: 461-467.
21. Meijnen P, Peterse JL, Oldenburg HS, et al.: Changing patterns in diagnosis and treatment of ductal carcinoma in situ of the breast, Eur J Surg Oncol 2005;31:833-839.
22. Al Sobhi SS, Helvie MA, Pass HA, et al.: Extent of lumpectomy for breast cancer after diagnosis by stereotactic core versus wire, localization biopsy. Ann Surg Oncol 1999;6:330-335.
23. Goyal A, Douglas-Jones A, Monypenny 1, et al.: Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ? Analysis 44, of 587 cases. Breast Cancer Res Treat 2006.
24. Meijnen P, Oldenburg HS, Loo CE, et al.: Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy. Br J Surg 2007;94:952-956.
25. Mittendorf EA, Arciero CA, Gutchell V, et al.: Core biopsy diagnosis of ductal carcinoma in situ: An indication for sentinel lymph node biopsy. Curr Surg 2005;62:253-257.
26. Wilkie C, White L, Dupont E, et al.: An update of sentinel lymph node mapping in patients with ductal carcinoma in situ, Am J Surg 2005;190:563-566.
27. Yen TW, Hunt KK, Ross MI, et al.: Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: A guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg 2005; 200:516-526.
28. Cordiner CM, Litherland JC, Young IE: Does the insertion of more than one wire allow successful excision of large clusters of malignant calcification? Clin Radiol 2006;61:686-690.
29. Rampaul RS, Bagnall M, Burrell H, et al.: Randomized clinical trial comparing radioisotope occult lesion localization and wire-guided excision for biopsy of occult breast lesions. Br J Sura 2004;91:1575-1577.
30. van der Ploeg IM, Hobbelink M, van den Bosch MA, et al.: Radioguided occult lesion localisation' (ROLL) for non-palpable breast lesions: A review of the relevant literature. Eur J Surg Oncol 2007.
31. Bennett IC, Greenslade J, Chiam H: Intraoperative ultrasound-guided excision of nonpalpable breast lesions. World J Surg 2005: 29:369-374.
32. Tamaki Y. Akashi-Tanaka S, Ishida T, et al.: 3D imaging of intraductal spread of breast cancer and its clinical application for navigation surgery. Breast Cancer 2002;9:289-295.
33. Wallace AM, Daniel BL, Jeffrey SS, et al.: Rates of reexcision for breast cancer after magnetic resonance imaging-guided bracket wire localization. J Am Coll Surg 2005;200:527-537.
34. Silverstein MJ, Lagios MD, Groshen S, et al.: The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 1999;340:1455-1461.
35. Wong JS, Kaelin CM, Troyan SL, et al.: Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol 2006;24:1031-1036.
36. Hughes L, Wang M, Page D, Gray R, Solin L, Davidson N, Lowen M, Ingle J, Wood W: Five year results of intergroup study E5194: Local excision alone (without radiation treatment) for selected patients with ductal carcinoma in situ (DCIS). Breast Cancer Res Treat 2006;100:S15. Ref Type: Abstract.
37. Macdonald HR, Silverstein MJ, Mabry H, et al.: Local control in ductal carcinoma in situ treated by excision alone: Incremental benefit of larger margins. Am J Surg 2005;190:521-525.
38. Cheng L, Al Kaisi NK, Gordon NH, et al.: Relationship between the size and margin status of ductal carcinoma in situ of the breast and residual disease. J Natl Cancer Inst 1997:89:1356-1360.
39. Douglas-Jones AG, Logan J, Morgan JM, et al.: Effect of margins of excision on recurrence after local excision of ductal carcinoma in situ of the breast. J Clin Pathol 2002;55:581 -586.
40. Goldstein NS, Kestin L, Vicini F: Intraductal carcinoma of the breast: Pathologic features associated with local recurrence in patients treated with breast-conserving therapy. Am J Sure Pathol 2000;24:1058-1067.
41. Schnitt SJ: The diagnosis and management of pre-invasive breast disease: Flat epithelial atypia-Classification, pathologic features and clinical significance. Breast Cancer Res 2003:5:263-268.
42. Bijker N, Peterse JL, Duchateau L, et al.: Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoiria-in-situ: Analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 2001;19:2263-2271.
43. Eusebi V, Feudale E, Foschini MP, et al.: Long-term follow-up of in situ carcinoma of the breast. Semin Diagn Pathol 1994; 11:223-235.
44. Tavassoli FA, Devilee P: World Health Organization, classification of tumours, pathology and genetics: Tumours of the breast and female genital organs. Lyon: International Agency for Research on Cancer Press; 2003.
45. Greene T, Tartter PI, Smith SR, et al.: The significance of surgical margins for patients with atypical ductal hyperplasia. Am J Surg 2006; 192:499-501.
46. Bedrosian I, Mick R. Orel SG, et al.: Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer 2003;98: 468-473.
47. Deurloo EE, Klein Zeggelink WF, Teertstra HJ, et al.: Contrast-enhanced MRI in breast cancer patients eligible for breast-conserving therapy: Complementary value for subgroups of patients. Eur Radiol 2006;16:692-70l.
48. Liberman L, Morris EA, Dershaw DD, et al.: MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. Am J Roentgenol 2003; 180:901-910.
49. Neubauer H, Li M, Kuehne-Heid R, et al.: High grade and non-high grade ductal carcinoma in situ on dynamic MR mammography: Characteristic findings for signal increase and morphological pattern of enhancement. Br J Radiol 2003:76: 3-12.
50. Schouten van der Velden AP, Boetes C, Bult P, et al.: The value of magnetic resonance imaging in diagnosis and size assessment of in situ and small invasive breast carcinoma. Am J Surg 2006;! 92: 172-178.
51. Soderstrom CE, Harms SE, Copit DS, et al.: Three-dimensional RODEO breast MR imaging of lesions containing ductal carcinoma in situ. Radiology 1996;201:427-432.
52. Viehweg P, Lampe D, Buchmann J, et al.: In situ and minimally invasive breast cancer: Morphologic and kinetic features on contrast-enhanced MR imaging. MAGMA 2000; 11:129-137.
53. Westerhof JP, Fischer U, Moritz JD, et al.: MR imaging of mammographically detected clustered microcalcifications: Is there any value? Radiology 1998;207:675-681.
54. Kutal CK, Jost P, Morakkabati N, et al.: Contrast-enhanced MR imaging of the breast at 3.0 and 1, 5 T in the same patients: Initial experience. Radiology 2006;239:666-676.
55. Esserman L, Hylton N, Yassa L, et al.: Utility of magnetic resonance imaging in the management of breast cancer: Evidence for improved preoperative staging. J Clin Oncol 1999; 17:110-119.
56. Gilles R, Zafrani B, Guinebretiere JM, et al.: Ductal carcinoma in situ: MR imaging-histopathologic correlation. Radiology 1995; 196:415-419.
57. Esserman LJ, Kumar AS, Herrera AF, et al.: Magnetic resonance imaging captures the biology of ductal carcinoma in situ. J Clin Oncol 2006;24:4603-4610.
58. Kuhl CK, Schrading S, Bieling HB, et al,: MRI for diagnosis of pure ductal carcinoma in situ: A prospective observational study. Lancet 2007;370:485-492.
59. Ernster VL, Ballard-Barbash R, Barlow WE, et al.: Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 2002;94:1546-1554.
60. Kopans DB, Rafferty E, Georgian-Smith D, et al.: A simple model of breast carcinoma growth may provide explanations for observations of apparently complex phenomena. Cancer 2003; 97:2951-2959.
61. Welch HG, Black WC: Using autopsy series to estimate the disease "reservoir" for ductal carcinoma in situ of the breast: How much more breast cancer can we find? Ann Intern Med 1997; 127:1023-1028.
62. Niklason LT, Christian BT, Niklason LE, et al,: Digital tomosyn-thesis in breast imaging. Radiology 1997;205:399-406.